{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/3630b84a-e3b9-4c23-8e38-b03d2fb26ee0?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Mr Nice's Neil Mahapatra: \"Every mammal can get high\"","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/61ba0b4a40076a0012722d72.jpg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Neil Mahapatra, founder of Kingsley Capital and Oxford Cannabinoid Technologies, to talk about his early days in investment banking (3:30), getting a job with Lord Rothschild (5:50), setting up his own investment firm (7:30), how his mother’s lung cancer changed everything (8:15), why the stoners won’t make it (12:45), carving out a beachhead (15:15), building credibility for weed (18:40), the plant’s legal status in Britain (22:30), its potential as a cancer treatment (23:00), what a cannabinoid is (25:50), getting Snoop Dogg as an investor (28:15), developing drugs (29:50), and a consumer brand (32:30), Mr Nice (33:45), Oprah’s cannabis venture (36:15), sourcing the plant (38:50), and waiting for the laws to catch up (39:45).</p>","author_name":"The Sunday Times"}